Kimberly-Clark Acquires Kenvue in $49 Billion Deal
Consumer giant Kimberly-Clark, maker of Huggies diapers and Kleenex tissues, is buying Kenvue, the company behind Tylenol and Band-Aids, in a $49 billion merger.
The deal comes amidst controversy surrounding Tylenol, after the Trump administration linked its active ingredient, acetaminophen, to autism, despite lacking clear scientific evidence. Kenvue has disputed these claims as "simply false."
According to Kimberly-Clark CEO Mike Hsu, the merger will create "a global health and wellness leader" by combining the two "iconic companies."
- Tylenol
- Band-Aids
- Listerine
- Neutrogena
- Aveeno
The acquisition expands Kimberly-Clark's portfolio of consumer brands, adding a new range of pharmacy staples.
Author's summary: Kimberly-Clark buys Kenvue for $49 billion.